title: [A case of metastatic colorectal cancer suffering from hyperammonemic encephalopathy induced by 5-FU, continuously treated with FOLFOX therapy].
abstract: We report a rare case of metastatic colorectal cancer who suffered from hyperammonemic encephalopathy induced by 5- FU and was continuously treated with FOLFOX therapy. A 50-year-old man with ileus was diagnosed with ascending colon cancer Stage IV, and a right hemicolectomy was performed. Postoperative chemotherapy with modified FOLFOX6 was performed. Complications of nausea and vomiting were seen on day 2 , with confusion and cognitive disturbances on day 3 . None of the other radiographic examinations provided an explanation for his symptoms. Laboratory examination revealed hyperammonemia, so branched-chain amino acid solutions and high-volume drip infusion were started for its treatment. His symptoms entirely disappeared on day 4. We changed to chemotherapy for FOLFOX4 using branched-chain amino acid solutions and drip infusion. The tumor marker level normalized following two courses, and CT following ten courses showed that the size of the lung metastasis and abdominal lymph node had reduced significantly. The patient is currently receiving FOLFOX4.
authors: Dept. of Gastroenterology, Yamagata City Hospital Saiseikan.
authors: Hirokazu
authors: H
authors: Shoji
authors: Michio
authors: M
authors: Kuroki
authors: Keiichiro
authors: K
authors: Hiramoto
authors: Yoshifumi
authors: Y
authors: Matsumura
authors: Atsushi
authors: A
authors: Miura
authors: Yoshifumi
authors: Y
authors: Kikuchi
authors: Hidetoshi
authors: H
authors: Hirakawa
mesh_terms: D000597:Amino Acids, Branched-Chain / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D022124:Hyperammonemia / Q000139:chemically induced* / Q000517:prevention & control; D002955:Leucovorin / Q000009:adverse effects / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D000597:Amino Acids, Branched-Chain; D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil